|
SCYL3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.01780000486096E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.85419999856984E-08 |
| Normal-vs-Stage2 |
4.42239999998151E-06 |
| Normal-vs-Stage3 |
6.007100E-04 |
| Normal-vs-Stage4 |
2.510400E-02 |
| Stage1-vs-Stage2 |
9.406600E-01 |
| Stage1-vs-Stage3 |
6.799600E-01 |
| Stage1-vs-Stage4 |
9.869800E-01 |
| Stage2-vs-Stage3 |
6.621200E-01 |
| Stage2-vs-Stage4 |
9.507600E-01 |
| Stage3-vs-Stage4 |
8.019800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.68960000119279E-08 |
| Normal-vs-AfricanAmerican |
1.25739999967678E-07 |
| Normal-vs-Asian |
1.649800E-04 |
| Caucasian-vs-AfricanAmerican |
3.979400E-01 |
| Caucasian-vs-Asian |
4.896200E-01 |
| AfricanAmerican-vs-Asian |
5.197600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.55000045920906E-10 |
| Normal-vs-Female |
2.035800E-02 |
| Male-vs-Female |
9.676700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.595400E-04 |
| Normal-vs-Extreme_Weight |
2.72410000112799E-08 |
| Normal-vs-Obese |
3.04610000001482E-07 |
| Normal-vs-Extreme_Obese |
2.04889999999569E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.738800E-01 |
| Normal_Weight-vs-Obese |
7.803800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.994000E-01 |
| Extreme_Weight-vs-Obese |
4.303600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.179200E-01 |
| Obese-vs-Extreme_Obese |
3.639800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.56940999999078E-05 |
| Normal-vs-Age(41-60Yrs) |
8.48629999999906E-05 |
| Normal-vs-Age(61-80Yrs) |
1.39309996871617E-09 |
| Normal-vs-Age(81-100Yrs) |
3.13559999964852E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.482400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.975600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.369960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.555700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.063500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.651590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.80790000431963E-08 |
| Normal-VS-Type2 PRCC |
6.41690001135231E-09 |
| Normal-VS-KIRP CIMP |
1.13739999996199E-06 |
| Normal-VS-Unclassified PRCC |
4.009300E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.649020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.686640E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.166400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.274000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.330400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.502830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.06609984465933E-10 |
| Normal-vs-N1 |
3.059700E-02 |
| Normal-vs-N2 |
2.282500E-03 |
| N0-vs-N1 |
6.841800E-02 |
| N0-vs-N2 |
7.851600E-01 |
| N1-vs-N2 |
3.403600E-01 |
|
|
